If that is true, my model suggests about 50 recurrences in the Control group and around 20 in the NeuVax group in December, equating to approximately a 60% improvement in DFS for NeuVax treated patients. How important is this? Assume an annual WW patient population of 100,000 for these BC patients and a 60% improvement with NeuVax would translate into 12,000 saved lives per year!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.